Valeant Bounces On Pearson's 'Road To Recovery'
This article was originally published in Scrip
Executive Summary
Shares of Valeant Pharmaceuticals International Inc. got an 8% bounce on Jan. 25 after Michael Pearson, who has been on medical leave since late last month after experiencing complications while hospitalized with severe pneumonia, said he was on "the road to recovery," although he said the timing of his return "remains uncertain."